Neuroimaging and neurocircuitry models pertaining to the neurosurgical treatment of psychiatric disorders

Neurosurgery Clinics of North America

Volumn 14, Issue 2, 2003, Pages 213-223

  Rauch, Scott L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; N ACETYLASPARTIC ACID; SEROTONIN UPTAKE INHIBITOR;

AMYGDALOID NUCLEUS; ANTERIOR CAPSULOTOMY; ANTERIOR CINGULOTOMY; ANXIETY DISORDER; BEHAVIOR THERAPY; BRAIN ATROPHY; BRAIN METABOLISM; CAPSULA INTERNA; CINGULATE GYRUS; COGNITION; DEPRESSION; DIAGNOSTIC IMAGING; HIPPOCAMPUS; HUMAN; IMAGING SYSTEM; LIMBIC LEUKOTOMY; LIMBIC SYSTEM; MAJOR DEPRESSION; MENTAL DISEASE; MODEL; NEUROANATOMY; NEURORADIOLOGY; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBSESSIVE COMPULSIVE DISORDER; ORBITAL CORTEX; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOSURGERY; REVIEW; SUBCAUDATE TRACTOTOMY; SURGICAL TECHNIQUE; THALAMUS;

EID: 0037399306     PISSN: 10423680     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1042-3680(02)00114-6     Document Type: Review

References (117)

1. Dougherty DD, Rauch SL, editors. Psychiatric neuroimaging research: contemporary strategies. Washington. DC: American Psychiatric Publishing; 2001.
2. Dougherty DD, Rauch SL. Neuroimaging and neurobiological models of depression. Harvard Rev Psychiatry 1997;5:138-59.
3. Rauch SL, Baxter LR. Neuroimaging of OCD and related disorders. In: Jenike MA, Baer L, Minichiello WE, editors. Obsessive-compulsive disorders: practical management. Boston: Mosby; 1998. p. 289-317.
4. Rauch SL, Cora-Locatelli G, Greenberg BD. Pathogenesis of OCD. In: Stein DJ, Hollander E, editors. Textbook of anxiety disorders. Washington, DC: American Psychiatric Press; 2002. p. 191-206.
5. Rauch SL, Cosgrove GR. Neurosurgical treatments for psychiatric diseases. In: Kaplan HI, Sadock BJ, editors. Comprehensive textbook of psychiatry. 7th edition. Baltimore: Williams & Wilkins; 1999. p. 2516-21.
6. Rauch SL, Whalen PJ, Dougherty DD, Jenike MA. Neurobiological models of obsessive compulsive disorders. In: Jenike MA, Baer L, Minichiello WE, editors. Obsessive-compulsive disorders: practical management. Boston: Mosby; 1998. p. 222-53.
7. Alexander GE, Crutcher MD, DeLong MR. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog Brain Res 1990;85:119-46.
8. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986;9:357-81.
9. Saxena S, Brody AL, Schwartz JM, Baxter LR. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry 1998;35:26-37.
10. Baxter LR, Schwartz JM, Guze BH, et al. Neuroimaging in obsessive-compulsive disorder: seeking the mediating neuroanatomy. In: Jenike MA, Baer L, Minichiello WE, editors. Obsessive compulsive disorder: theory and management. 2nd edition. Chicago: Year Book Medical Publishers; 1990. p. 167-88.
11. Haber SN, Fudge JL, McFarland NR. Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J Neurosci 2000;20:2369-82.
12. Jenike MA, Breiter HC, Baer L, et al. Cerebral structural abnormalities in obsessive-compulsive disorder: a quantitative morphometric magnetic resonance imaging study. Arch Gen Psychiatry 1996;53:625-32.
13. Robinson D, Wu H, Munne RA, et al. Reduced caudate nucleus volume in obsessive-compulsive disorder. Arch Gen Psychiatry 1995;52:393-8.
14. Scarone S, Colombo C, Livian S, et al. Increased right caudate nucleus size in obsessive compulsive disorder: detection with magnetic resonance imaging. Psychiatry Res Neuroimaging 1992;45:115-21.
15. Peterson B, Riddle MA, Cohen DJ, et al. Reduced basal ganglia volumes in Tourette's syndrome using three-dimensional reconstruction techniques from magnetic resonance images. Neurology 1993;43:941-9.
16. Singer HS, Reiss AL, Brown JE, et al. Volumetric MRI changes in basal ganglia of children with Tourette's syndrome. Neurology 1993;43:950-6.
17. O'Sullivan R, Rauch SL, Breiter HC, et al. Reduced basal ganglia volumes in trichotillomania by morphometric MRI. Biol Psychiatry 1997;42:39-45.
18. Rauch SL, Phillips KP, Segal E, et al. A preliminary morphometric magnetic resonance imaging study of regional brain volumes in body dysmorphic disorder. Psychiatry Res Neuroimaging [in press].
19. Aylward EH, Harris GJ, Hoehn-Saric R, et al. Normal caudate nucleus in obsessive-compulsive disorder assessed by quantitative neuroimaging. Arch Gen Psychiatry 1996;53:577-84.
20. Bartha R, Stein MB, Williamson PC, et al. A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessivecompulsive disorder and comparison subjects. Am J Psychiatry 1998;155:1584-91.
21. Ebert D, Speck O, Konig A, et al. H-magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for neuronal loss in the cingulate gyrus and the right striatum. Psychiatry Res Neuroimaging 1996;74:173-6.
22. Ohara K, Isoda H, Suzuki Y, et al. Proton magnetic resonance spectroscopy of lenticular nuclei in obsessive-compulsive disorder. Psychiatry Res 1999;92:83-91.
23. Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 1998; 155:264-71.
24. Breiter HC, Filipek PA, Kennedy DN, et al. Retrocallosal white matter abnormalities in patients with obsessive-compulsive disorder. Arch Gen Psychiatry 1994;51:663-4.
25. Szeszko PR, Robinson D, Alvir JM, et al. Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder. Arch Gen Psychiatry 1999;56:913-9.
26. Gilbert AR, Moore GJ, Keshavan MS, et al. Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine. Arch Gen Psychiatry 2000;57:449-56.
27. Rosenberg DR, Keshavan MS, O'Hearn KM, et al. Frontostriatal measurement in treatment.naive children with obsessive-compulsive disorder. Arch Gen Psychiatry 1997;54:824-30.
28. Baxter LR, Schwartz JM, Mazziotta JC, et al. Cerebral glucose metabolic rates in non-depressed obsessive-compulsives. Am J Psychiatry 1988;145:1560-1563.
29. Nordahl TE, Benkelfat C, Semple WE, et al. Cerebral glucose metabolic rates in obsessive-compulsive disorder. Neuropsychopharmacology 1989;2:23-8.
30. Swedo SE, Schapiro MG, Grady CL, et al. Cerebral glucose metabolism in childhood onset obsessive-compulsive disorder. Arch Gen Psychiatry 1989;46:518-23.
31. Breiter HC, Rauch SL, Kwong KK, et al. Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry 1996;49:595-606.
32. Cottraux J, Gerard D, Cinotti L, et al. A controlled positron emission tomography study of obsessive and neutral auditory stimulation in obsessive-compulsive disorder with checking rituals. Psychiatry Res 1996;60:101-12.
33. McGuire PK, Bench CJ, Frith CD, et al. Functional anatomy of obsessive-compulsive phenomena. Br J Psychiatry 1994;164:459-68.
34. Rauch SL, Jenike MA, Alpert NM, et al. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry 1994;51:62-70.
35. Rauch SL, Savage CR, Alpert NM, et al. A positron emission tomographic study of simple phobic symptom provocation. Arch Gen Psychiatry 1995;52:20-8.
36. Rauch SL, van der Kolk BA, Fisler RE, et al. A symptom provocation study of posttraumatic stress disorder using positron emission tomography and script-driven imagery. Arch Gen Psychiatry 1996;53:380-7.
37. Benkelfat C, Bradwejn J, Meyer E, et al. Functional neuroanatomy of CCK4-induced anxiety in normal healthy volunteers. Am J Psychiatry 1995;152:1180-4.
38. Baxter LR, Schwartz JM, Bergman KS, et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessivecompulsive disorder. Arch Gen Psychiatry 1992;49:681-9.
39. Benkelfat C, Nordahl TE, Semple WE, et al. Local cerebral glucose metabolic rates in obsessivecompulsive disorder: patients treated with clomipramine. Arch Gen Psychiatry 1990;47:840-8.
40. Schwartz JM, Stoessel PW, Baxter LR, et al. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 1996;53:109-13.
41. Swedo SE, Pietrini P, Leonard HL, et al. Cerebral glucose metabolism in childhood-onset obsessivecompulsive disorder: revisualization during pharmacotherapy. Arch Gen Psychiatry 1992;49:690-4.
42. Brody AL, Saxena S, Schwartz JM, et al. FDGPET predictors of response to behavioral therapy versus pharmacotherapy in obsessive-compulsive disorder. Psychiatry Res Neuroimaging 1998;84:1-6.
43. Rauch SL, Shin LM, Dougherty DD, et al. Predictors of fluvoxamine response in contamination-related obsessive compulsive disorder: a PET symptom provocation study. Neuropsychopharmacology 2002;27:782-91.
44. Saxena S, Brody AL, Maidment KM, et al. Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder. Neuropsychopharmacology 1999;21:683-93.
45. Mansari ME, Bouchard C, Blier P. Alteration of serotonin release in the guinea pig orbito-frontal cortex by selective serotonin reuptake inhibitors. Neuropsychopharmacology 1995;13:117-27.
46. Doyon J, Owen AM, Petrides M, et al. Functional anatomy of visuomotor skill learning in human subjects examined with positron emission tomography. Eur J Neurosci 1996;8:637-48.
47. Rauch SL, Savage CR, Brown HD, et al. A PET investigation of implicit and explicit sequence learning. Hum Brain Mapping 1995;3:271-86.
48. Rauch SL, Whalen PJ, Savage CR, et al. Striatal recruitment during an implicit sequence learning task as measured by functional magnetic resonance imaging. Hum Brain Mapping 1997;5:124-32.
49. Rauch SL, Savage CR, Alpert NM, et al. Probing striatal function in obsessive compulsive disorder: a PET study of implicit sequence learning. J Neuropsychiatry 1997;9:568-73.
50. Rauch SL, Whalen PJ, Curran T, et al. Probing striato-thalamic function in OCD and TS using neuroimaging methods. In: Cohen DJ, Jankovic J, Goetz CG, editors. Tourette syndrome. Advances in neurology. Philadelphia: Lippincott, Williams & Wilkins; 2001. p. 207-24.
51. Schacter DL, Alpert NM, Savage CR, Rauch SL, Albert MS. Conscious recollection and the human hippocampal formation: evidence from positron emission tomography. Proc Natl Acad Sci USA 1996;93:321-5.
52. Rauch SL, Whalen PJ, Curran T, et al. Thalamic deactivation during early implicit sequence learning: a functional MRI study. Neuroreport 1998;9:865-70.
53. Saxena S, Brody AL, Ho ML, et al. Cerebral metabolism in major depression and obsessivecompulsive disorder occurring separately and concurrently. Biol Psychiatry 2001;50:159-70.
54. Saxena S, Brody AL, Ho ML, et al. Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression. Arch Gen Psychiatry 2002;59:250-61.
55. Drevets WC. Neuroimaging studies of mood disorders. Biol Psychiatry 2000;48:813-29.
56. Drevets WC, Price JL, Simpson JR, et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997;386:824-27.
57. Mayberg HS. Limbic-cortical dysregulation: a proposed model of depression. J Neuropsychiatry Clin Neurosci 1997;9:471-81.
58. Mayberg HS, Brannan SK, Tekell JL, et al. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry 2000;48:830-43.
59. Mayberg HS, Liotti M, Brannan S, et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 1999;156:675-82.
60. Sheline YI. 3D MRI studies of neuroanatomic changes in unipolar major depression: the role of stress and medical comorbidity. Biol Psychiatry 2000;48:791-800.
61. Swerdlow NR, Koob GF. Dopamine, schizophrenia, mania and depression: toward a unified hypothesis of cortico-striato-pallido-thalamic function. Behav Brain Sci 1987;10:197-245.
62. Drevets WC, Raichle ME. Reciprocal suppression of regional cerebral blood flow during emotional versus higher cognitive processes. Implications for interactions between emotion and cognition. Cogn Emotion 1998;12:353-85.
63. Shulman GL, Corbetta M, Buckner RL, et al. Common blood flow changes across visual tasks:. II. Decrease in cerebral cortex. J Cogn Neurosci 1997;9:647-62.
64. Whalen PJ, Bush G, McNally RJ, et al. The emotional counting Stroop paradigm: an fMRI probe of the anterior cingulate affective division. Biol Psychiatry 1998;44:1219-28.
65. Kaufman J, Plotsky PM, Nemeroff CB, Charney DS. Effects of early adverse experiences on brain structure and function: clinical implications. Biol Psychiatry 2000;48:778-90.
66. Bremner JD, Narayan M, Anderson ER, et al. Hippocampal volume reduction in major depression. Am J Psychiatry 2000;157:115-8.
67. Mervaala E, Fohr J, Kononen M, et al. Quantitative MRI of the hippocampus and amygdala in severe depression. Psychol Med 2000;30:117-25.
68. Sheline YI, Sanghavi M, Mintun MA, Gado MH. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 1999;19:5034-43.
69. Sheline YI, Wang PW, Gado MH, et al. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 1996;93:3908-13.
70. Steffens DC, Byrum CE, McQuoid DR, et al. Hippocampal volume in geriatric depression. Biol Psychiatry 2000;48:301-9.
71. Vakilli K, Pillay SS, Lafer B, et al. Hippocampal volume in primary unipolar depression: a magnetic resonance imaging study. Biol Psychiatry 2000;47:1087-90.
72. Husain MM, McDonald WM, Doraiswamy PM, et al. A magnetic resonance imaging study of putamen nuclei in major depression. Psychiatry Res 1991;40:95-9.
73. Krishnan KR, McDonald WM, Escalona PR, et al. Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations. Arch Gen Psychiatry 1992;49:553-7.
74. Lenze EJ, Sheline YI. Absence of striatal volume differences between depressed subjects with no comorbid medical illness and matched comparison subjects. Am J Psychiatry 1999;156:1989-91.
75. Pillay SS, Renshaw PF, Bonello CM, et al. A quantitative magnetic resonance imaging study of caudate and lenticular nucleus gray matter volume in primary unipolar major depression: relationship to treatment response and clinical severity. Psychiatry Res 1998;84:61-74.
76. Dupont RM, Jernigan TL, Heindel W, et al. Magnetic resonance imaging and mood disorders. Localization of white matter and other subcortical abnormalities. Arch Gen Psychiatry 1995;52:747-55.
77. Coffey CE, Wilkinson WE, Weiner RD, et al. Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study. Arch Gen Psychiatry 1993;50:7-16.
78. Botteron KN, Raichle ME, Drevets WC, et al. Volumetric reduction in left subgenual prefrontal cortex in early onset depression. Biol Psychiatry 2002;51:342-4.
79. Bremner JD, Vythilingam M, Vermetten E, et al. Reduced volume of orbitofrontal cortex in major depression. Biol Psychiatry 2002;51:273-9.
80. Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 1998;95:13290-5.
81. Rajkowska G, Miguel-Hidalgo JJ, Wei J, et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 1999;45:1085-98.
82. Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry 2000;48:766-77.
83. Baxter LR Jr, Phelps ME, Mazziotta JC, et al. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry 1987;44:211-8.
84. Biver F, Goldman S, Delvenne V, et al. Frontal and parietal metabolic disturbances in unipolar depression. Biol Psychiatry 1994;36:381-8.
85. Cohen RM, Gross M, Nordahl TE, et al. Preliminary data on the metabolic brain pattern of patients with winter seasonal affective disorder. Arch Gen Psychiatry 1992;49:545-52.
86. Drevets WC, Videen TO, Price JL, et al. A functional anatomical study of unipolar depression. J Neurosci 1992;12:3628-41.
87. Ebert D, Feistel H, Barocka A. Effects of sleep deprivation on the limbic system and the frontal lobes in affective disorders: a study with Tc-99mHMPAO SPECT. Psychiatry Res 1991;40:247-51.
88. Buchsbaum MS, Wu J, Siegel BV, et al. Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol Psychiatry 1997; 41:15-22.
89. George MS, Ketter TA, Parekh PI, et al. Brain activity during transient sadness and happiness in healthy women. Am J Psychiatry 1995;152:341-351.
90. Brody AL, Saxena S, Silverman DH, et al. Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatry Res 1999;91:127-39.
91. Baxter LR Jr, Schwartz JM, Phelps ME, et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 1989;46:243-50.
92. Bench CJ, Frackowiak RS, Dolan RJ. Changes in regional cerebral blood flow on recovery from depression. Psychol Med 1995;25:247-61.
93. George MS, Ketter TA, Parekh PI, et al. Blunted left cingulate activation in mood disorder subjects during a response interference task (the Stroop). J Neuropsychiatry Clin Neurosci 1997;9:55-63.
94. Wu JC, Gillin JC, Buchsbaum MS, et al. Effect of sleep deprivation on brain metabolism of depressed patients. Am J Psychiatry 1992;149:538-43.
95. Breiter HC, Etcoff NL, Whalen PJ, et al. Response and habituation of the human amygdala during visual processing of facial expression. Neuron 1996;17:875-87.
96. Morris JS, Frith CD, Perrett DI, et al. A differential neural response in the human amygdala to fearful and happy facial expressions. Nature 1996;383:812-5.
97. Whalen PJ, Rauch SL, Etcoff NL, et al. Masked presentations of emotional facial expressions modulate amygdala activity without explicit knowledge. J Neurosci 1998;18:411-8.
98. Rauch SL, Whalen PJ, Shin LM, et al. Exaggerated amygdala responses to masked facial stimuli in posttraumatic stress disorder: a functional MRI study. Biol Psychiatry 2000;47:769-76.
99. Sheline YI, Barch DM, Donnelly JM, et al. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol Psychiatry 2001;50:651-8.
100. Wright CI, Fischer H, Whalen PJ, et al. Differential habituation in the prefrontal cortex and amygdala to repeatedly presented emotional facial stimuli. Neuroreport 2001;12:379-83.
101. Rauch SL, Shin LM, Wright CI. Neuroimaging studies of amygdala function in anxiety disorders. Ann NY Acad Sci [in press].
102. Cohen RM, Semple WE, Gross M, et al. Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia. Neuropsychopharmacology 1989;2:241-54.
103. Mayberg HS, Brannan SK, Mahurin RK, et al. Cingulate function in depression: a potential predictor of treatment response. Neuroreport 1997;8:1057-61.
104. Rauch SL, Kim H, Makris N, et al. Volume reduction in caudate nucleus following stereotactic lesions of anterior cingulate cortex in humans: a morphometric magnetic resonance imaging study. J Neurosurg 2000;93:1019-25.
105. Mufson EJ, Pandya DN. Some observations on the course and composition of the cingulum bundle in the rhesus monkey. J Comp Neurol 1984;225:31-43.
106. Rauch SL, Makris N, Cosgrove GR, et al. A magnetic resonance imaging study of regional cortical volumes following stereotactic anterior cingulotomy. CNS Spectrums 2001;6:214-22.
107. Cavada C, Company T, Tejedor J, et al. The anatomical connections of the macaque monkey orbitofrontal cortex. Cereb Cortex 2000;10:220-42.
108. Kemp JM, Powell TPS. The cortico-striate projections in the monkey. Brain 1970;93:525-46.
109. Vogt BA, Pandya DN. Cingulate cortex of the rhesus monkey; II. Cortical afferents. J Comp Neurol 1987;262:271-89.
110. Zald DH, Kim SW. Anatomy and function of the orbital frontal cortex, I: anatomy, neurocircuitry, and obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci 1996;8:125-38.
111. Rauch SL, Dougherty DD, Cosgrove GR, et al. Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for obsessive compulsive disorder. Biol Psychiatry 2001;50:659-667.
112. Amaral DG, Price JL. Amygdalo-cortical projections in the monkey. J Comp Neurol 1984;230:465-96.
113. Sachdev P, Trollor J, Walker A, et al. Bilateral orbitomedial leucotomy for obsessive-compulsive disorder: a single-case study using positron emission tomography. Aust NZ J Psychiatry 2001;35:684-90.
114. Sawle GV, Lees AJ, Hymas NF, et al. The metabolic effects of limbic leucotomy in Gilles de la Tourette syndrome. J Neurol Neurosurg Psychiatry 1993;56:1016-9.
115. Lippitz BE, Mindus P, Meyerson BA, et al. Lesion topography and outcome after thermocapsulotomy or gamma knife capsulotomy for obsessive-compulsive disorder: relevance of the right hemisphere. Neurosurgery 1999;144:452-8.
116. Mindus P, Ericson K, Greitz T, et al. Regional cerebral glucose metabolism in anxiety disorders studied with positron emission tomography before and after psychosurgical intervention. A preliminary report. Acta Radiol Suppl 1986;369:444-8.
117. Nuttin B, Cosyns P, Demeulemeester H, et al. Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder. Lancet 1999;354:1526.